JAKARTA: Indonesia’s Food and Drug Monitoring Agency (BPOM) has granted an emergency use authorisation of Pfizer’s antiviral drug, Paxlovid, to treat eligible Covid-19 patients.The approved film-coated Paxlovid contains 150 mg of nirmatrelvir co-packaged with 100 mg ritonavir, according to its head, Penny Kusumastuti Lukito.The recommended dose is 300 mg nirmatrelvir, equivalent to two 150 mg tablets, with a tablet of 100 mg ritonavir, taken twice a day for five days, she said in a statement.Previously, BPOM granted permits for two antiviral drugs, namely Favipiravir and Remdesivir in 2020, monoclonal antibody Regdanvimab (2021), and Molnupiravir (2022).The world’s fourth most populous count
Hence then, the article about indonesia approves pfizer s paxlovid pill to combat covid 19 was published today ( ) and is available onDaily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Indonesia approves Pfizer’s Paxlovid pill to combat Covid-19 )